Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 3

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Other 3

Conditions

Opioid-Induced Constipation 3Vomiting 1Neoplasms 1Nausea 1Constipation 1

Interventions

Cisplatin 3193Cyclophosphamide 3187Carboplatin 2968Radiotherapy 2784Paclitaxel 2716Gemcitabine 2569pembrolizumab 2378Bevacizumab 2206Docetaxel 2196Fluorouracil 1848Capecitabine 1828Oxaliplatin 1738Dexamethasone 1604Nivolumab 1580Doxorubicin 1501Rituximab 1487Magnetic Resonance Spectroscopy 1382Etoposide 1345Irinotecan 1245Leucovorin 1222Drug Therapy 1202Cytarabine 1130Pemetrexed 1074fludarabine 1056Specimen Handling 1009Vincristine 964Cetuximab 943Prednisone 940Trastuzumab 940Lenalidomide 937

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
naldemedine × Clear all
NCT07231796 2026-01-02

NOCON

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Recruiting
100 enrolled
Other

Opioid-Induced Constipation, Neoplasms

NCT07038551 2025-07-02

Prophylactic Use of Naldemedine on Opioid-induced Nausea and Vomiting in Patients With Cancer: POSEIDON Study

International University of Health and Welfare

Phase 4 Recruiting
120 enrolled
Other

Opioid-Induced Constipation, Constipation, Nausea, Vomiting

NCT03720613 2025-02-12

Risk of Major Adverse Cardiovascular Events for Naldemedine & Other Medications for Opioid Induced Constipation

BioDelivery Sciences International

Recruiting
34,532 enrolled
Other

Opioid-Induced Constipation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡